About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(tetO-Hgf,-EGFP)24Tcre
transgene insertion 24, Tiziana Crepaldi
MGI:5648118
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Pax7tm1Pgr/Pax7tm1Pgr
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
involves: 129S2/SvPas * 129X1/SvJ * FVB MGI:5882413
cx2
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Pax7tm1Pgr/Pax7+
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
involves: 129S2/SvPas * 129X1/SvJ * FVB MGI:5882414
cx3
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
involves: 129X1/SvJ * FVB MGI:5882410
cx4
Cdkn2atm1Cjs/Cdkn2a+
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
involves: 129X1/SvJ * FVB MGI:5882411
cx5
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
involves: FVB MGI:5882409


Genotype
MGI:5882413
cx1
Allelic
Composition
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Pax7tm1Pgr/Pax7tm1Pgr
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
Genetic
Background
involves: 129S2/SvPas * 129X1/SvJ * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdkn2atm1Cjs mutation (6 available); any Cdkn2a mutation (62 available)
Pax7tm1Pgr mutation (1 available); any Pax7 mutation (39 available)
Tg(CKMM-tTA)A3Rhvh mutation (2 available)
Tg(tetO-Hgf,-EGFP)24Tcre mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
• 29% of tumors are embryonal rhabdomyosarcoma

neoplasm
• 87% of mice develop sarcomas
• 71% of tumors that form in mice are undifferentiated pleomorphic sarcoma
• 29% of tumors are embryonal rhabdomyosarcoma




Genotype
MGI:5882414
cx2
Allelic
Composition
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Pax7tm1Pgr/Pax7+
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
Genetic
Background
involves: 129S2/SvPas * 129X1/SvJ * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdkn2atm1Cjs mutation (6 available); any Cdkn2a mutation (62 available)
Pax7tm1Pgr mutation (1 available); any Pax7 mutation (39 available)
Tg(CKMM-tTA)A3Rhvh mutation (2 available)
Tg(tetO-Hgf,-EGFP)24Tcre mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
• mice develop mainly embryonal rhabdomyosarcoma, with 92% of tumors being embryonal rhabdomyosarcoma

neoplasm
• 100% of mice develop sarcoma
• 8% of tumors are undifferentiated pleomorphic sarcoma
• mice develop mainly embryonal rhabdomyosarcoma, with 92% of tumors being embryonal rhabdomyosarcoma




Genotype
MGI:5882410
cx3
Allelic
Composition
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
Genetic
Background
involves: 129X1/SvJ * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdkn2atm1Cjs mutation (6 available); any Cdkn2a mutation (62 available)
Tg(CKMM-tTA)A3Rhvh mutation (2 available)
Tg(tetO-Hgf,-EGFP)24Tcre mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
• 32% of mice that develop embryonal rhabdomyosarcoma exhibit muscle hyperplasia while 68% of mice develop embryonal rhabdomyosarcoma without muscle hyperplasia
• all mice develop tumors, mainly multi-step embryonal rhabdomyosarcoma with a short latency of 3.95 months
• embryonal rhabdomyosarcoma originates from satellite cells
• treatment of mice with doxycycline when tumors become palpable does not impair tumor growth
• mice maintained under doxycycline treatment until P10 develop tumors after doxycycline removal

neoplasm
• all mice develop tumors, mainly multi-step embryonal rhabdomyosarcoma with a short latency of 3.95 months
• embryonal rhabdomyosarcoma originates from satellite cells
• treatment of mice with doxycycline when tumors become palpable does not impair tumor growth
• mice maintained under doxycycline treatment until P10 develop tumors after doxycycline removal

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
embryonal rhabdomyosarcoma DOID:3246 OMIM:268210
J:237183




Genotype
MGI:5882411
cx4
Allelic
Composition
Cdkn2atm1Cjs/Cdkn2a+
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
Genetic
Background
involves: 129X1/SvJ * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdkn2atm1Cjs mutation (6 available); any Cdkn2a mutation (62 available)
Tg(CKMM-tTA)A3Rhvh mutation (2 available)
Tg(tetO-Hgf,-EGFP)24Tcre mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
• mice develop multi-step embryonal rhabdomyosarcoma with a latency of 6 months
• majority of tumors lose the wild-type allele

neoplasm
• mice develop multi-step embryonal rhabdomyosarcoma with a latency of 6 months
• majority of tumors lose the wild-type allele




Genotype
MGI:5882409
cx5
Allelic
Composition
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
Genetic
Background
involves: FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(CKMM-tTA)A3Rhvh mutation (2 available)
Tg(tetO-Hgf,-EGFP)24Tcre mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
• myofibers contain more myonuclei than controls
• mice exhibit a modest reduction of muscle fiber size
• however, mice show normal postnatal muscle growth
• mice exhibit a higher number of satellite cells compared to controls
• MyoD-positive cells are seen in muscle sections indicating presence of activated satellite cells





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
07/02/2024
MGI 6.13
The Jackson Laboratory